Join the HIV Infection group to help and get support from people like you.
HIV Infection News
Related terms: Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome (AIDS), Acute HIV Infection, Acute Retroviral Syndrome, AIDS, AIDS-Related Complex, Chronic Symptomatic HIV Infection, HIV Infection, Acute, HIV Seroconversion Syndrome, Human Immunodeficiency Virus Infection, Primary HIV Infection, HIV, ARC, Acquired Immunodeficiency Syndrome, HIV/AIDS
Limited Progress on QoL Goals Reported for Persons With HIV Aged 50 Years and Older
FRIDAY, Sept. 13, 2024 – For persons diagnosed with HIV (PWH) aged 50 years and older, progress on quality of life (QoL) goals is limited, according to a study published online Sept. 12 in Morbidity...
Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access?
THURSDAY, Sept. 12, 2024 – It could be a real breakthrough for people at risk for HIV infection: A shot given every six months that reduces their risk by a whopping 96%. That's according to new...
Federal Judge Rules That U.S. Military Cannot Reject HIV-Positive Enlistees
FRIDAY, Aug. 23, 2024 – People with HIV can no longer be turned away if they try to enlist in the U.S. military, a federal judge has ruled. The decision, issued this week by U.S. District Judge...
Hep C Reinfection Observed in HIV-Positive Men Who Have Sex With Men
THURSDAY, Aug. 8, 2024 – The incidence rate of hepatitis C virus (HCV) reinfection was 4.7 per 100 person-years among men who have sex with men (MSM) with HIV who cleared HCV, according to a study...
Long-Acting Cabotegravir Well Tolerated in Pregnant Women
THURSDAY, Aug. 8, 2024 – Long-acting injectable cabotegravir (CAB-LA) appears to be well tolerated in pregnant women, according to a study presented at AIDS 2024, the 25th International AIDS...
Twice-Yearly Shot Protects At-Risk Women Against HIV
WEDNESDAY, July 24, 2024 – Just two shots a year of an HIV treatment provided complete protection against infections in highly at-risk women, researchers reported Wednesday. In the study of about...
Long-Acting Early Viral Inhibition Described in Context of Long-Acting Injectable Cabotegravir
MONDAY, July 29, 2024 – In a research letter published online July 24 in the New England Journal of Medicine, the authors describe long-acting early viral inhibition (LEVI) among patients with acute...
Twice-Yearly Lenacapavir Prevents HIV Infection in Young Women
FRIDAY, July 26, 2024 – For adolescent girls and young women, lenacapavir every 26 weeks is beneficial for preventing acquired HIV infection, according to a study published online July 24 in the New...
Twice-Yearly Shot Protects At-Risk Women Against HIV
WEDNESDAY, July 24, 2024 – Just two shots a year of an HIV treatment provided complete protection against infections in highly at-risk women, researchers reported Wednesday. In the study of about...
Behavioral Pain Self-Management Intervention Effective for Chronic Pain With HIV
WEDNESDAY, July 24, 2024 – A behavioral pain self-management intervention is effective for chronic pain in people living with HIV, according to a study published online July 15 in JAMA Internal ...
German Patient is 7th Person Probably Cured of HIV
FRIDAY, July 19, 2024 – A German man has become the seventh person to apparently be cured of HIV, researchers report. The 60-year-old man, referred to as the “next Berlin Patient,” was treated with a...
German Patient is 7th Person Probably Cured of HIV
FRIDAY, July 19, 2024 – A German man has become the seventh person to apparently be cured of HIV, researchers report. The 60-year-old man, referred to as the “next Berlin Patient,” was treated with a...
Thousands of Hospital Patients in Oregon May Have Been Exposed to Hepatitis, HIV
FRIDAY, July 12, 2024 – After an anesthesiologist may have exposed thousands of people treated at several hospitals in Oregon to hepatitis and HIV, those patients are being advised to get tested for...
Twice-a-Year Injection Gives Women Full Protection Against HIV, Trial Finds
MONDAY, June 24, 2024 – Just two injections a year of a new HIV drug protected young women in Africa from infection with the sexually transmitted disease, new trial results show. In announcing the...
Mailed HIV Self-Tests Can Improve Access to Testing in Priority Audiences
THURSDAY, June 20, 2024 – Mailed HIV-self tests (HIVSTs) can increase testing among persons who have never received testing for HIV or have not received testing in the past year, according to...
Further information
Related condition support groups
Pre-Exposure Prophylaxis, Viral Infection
Related drug support groups
Biktarvy, bictegravir / emtricitabine / tenofovir alafenamide, Genvoya, Triumeq